Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner Syndrome

Clinical trial NCT00266656 · COMPLETED

Trial details

NCT number: NCT00266656
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Turner Syndrome

Start date: 2005-12-01
Primary completion: 2015-09-01
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.